Literature DB >> 21421151

Special stains in Mohs surgery.

Christopher J Miller1, Joseph F Sobanko, Xiaodong Zhu, Terri Nunnciato, Christopher R Urban.   

Abstract

The excellent cure rates associated with Mohs micrographic surgery depend on accurate interpretation of complete and high-quality microscopic frozen sections. Reliable interpretation of microscopic slides is only possible if the surgeon can distinguish tumor cells from surrounding normal tissue. By highlighting tumor cells with a chromogen that is visible on light microscopy, immunostaining allows the Mohs surgeon to distinguish tumor from normal cells in these challenging scenarios. This article focuses on practical aspects involving the most commonly used immunostains in dermatologic surgery, including MART-1 for melanocytic neoplasms, cytokeratin stains for keratinocytic neoplasms, and CD34 stains for dermatofibrosarcoma protuberans.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21421151     DOI: 10.1016/j.det.2011.01.003

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN: 0733-8635            Impact factor:   3.478


  3 in total

1.  Deep learning automated pathology in ex vivo microscopy.

Authors:  Marc Combalia; Sergio Garcia; Josep Malvehy; Susana Puig; Alba Guembe Mülberger; James Browning; Sandra Garcet; James G Krueger; Samantha R Lish; Rivka Lax; Jeannie Ren; Mary Stevenson; Nicole Doudican; John A Carucci; Manu Jain; Kevin White; Jaroslav Rakos; Daniel S Gareau
Journal:  Biomed Opt Express       Date:  2021-05-05       Impact factor: 3.562

Review 2.  Current perspectives on Mohs micrographic surgery for melanoma.

Authors:  Derek Beaulieu; Ramin Fathi; Divya Srivastava; Rajiv I Nijhawan
Journal:  Clin Cosmet Investig Dermatol       Date:  2018-06-20

3.  Multiple recurrent squamous cell carcinomas and utility of anticytokeratin immunohistochemistry.

Authors:  Michael W Pelster; Sapna M Amin; Simon Yoo
Journal:  JAAD Case Rep       Date:  2016-08-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.